|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/09 | |
| A61K 39/385 | |||
| A61K 39/00 | |||
| A61K 47/64 | |||
| A61P 31/04 |
| (11) | Number of the document | 3096785 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15708580.4 |
| Date of filing the European patent application | 2015-01-15 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/050315 |
| Date | 2015-01-15 |
| (87) | Number | WO 2015/110941 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| 201461929547 P | 2014-01-21 | US |
| (72) |
COOPER, David, US
EMINI, Emilio Anthony, US
GU, Jianxin, US
HAN, Mingming, US
JANSEN, Kathrin Ute, US
KAINTHAN, Rajesh Kumar, US
KIM, Jin-Hwan, US
PRASAD, Avvari Krishna, US
PRIDE, Michael William, US
WATSON, Wendy Jo, US
YANG, Yu-Ying, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF |
| IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF |